Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

NCT00681577 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

BIOLOGICAL: URLC10, KOC1, VEGFR1 and VEGFR2

Sponsor

Tokyo University

Collaborators

[object Object]